Xin Xu
- Cancer Research top 2%
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 6
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 6
- Cancer-related Molecular Pathways 6
- Molecular Biology top 5%
- RNA modifications and cancer 12
- Circular RNAs in diseases 8
- Ubiquitin and proteasome pathways 6
- Cell Biology top 10%
- Immunology top 10%
-
- Esophageal Cancer Research and Treatment 8
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xin Xu
83 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 107
- Cancer Research 709
- Oncology 758
- Molecular Biology 1.4k
- Cell Biology 211
- Immunology 222
Countries citing papers authored by Xin Xu
This map shows the geographic impact of Xin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Xu more than expected).
Fields of papers citing papers by Xin Xu
This network shows the impact of papers produced by Xin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Xu. The network helps show where Xin Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 72 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 9 | |
| 10 | 2019 | 12 | |
| 11 | 2019 | 74 | |
| 12 | 2015 | 5 | |
| 13 | 2014 | 45 | |
| 14 | 2014 | 21 | |
| 15 | 2014 | 47 | |
| 16 | 2012 | 115 | |
| 17 | 2009 | 41 | |
| 18 | 2009 | 69 | |
| 19 | 2007 | 11 | |
| 20 | 2006 | 122 |
About Xin Xu
Xin Xu is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 84 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), MicroRNA in disease regulation (9 papers), Esophageal Cancer Research and Treatment (8 papers), Circular RNAs in diseases (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Cancer Research (709 citations), Oncology (758 citations) and Molecular Biology (1.4k citations). Xin Xu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Ming‐Rong Wang, Qimin Zhan, Yili Yang, Yan Cai, Kunkun Han, Yaling Han, Yan Cai, Man‐Li Luo, Jia‐Jie Hao and Wei Zhu. Their work appears in journals such as Nature Genetics, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.